Day 100 PET Scan Positivity Predicts for Worse Survival in Lymphoma Patients Given Allogeneic Peripheral Blood Stem Cells After Non-Myeloablative Conditioning

被引：0
|
作者：
Jaspers, Aurelie [1 ]
Fosse, Pacome [1 ]
Withofs, Nadia [1 ]
Lejeune, Marie [1 ]
Willems, Evelyne [1 ]
Hafraoui, Kaoutar [1 ]
Hustinx, Roland [1 ]
Baron, Frederic [2 ]
Beguin, Yves
机构：
[1] CHU Liege, Liege, Belgium
[2] Univ Liege, GIGA Res, Liege, Belgium
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1777 / 1778
页数：2
相关论文
共 50 条
  • [31] Outcomes of allogeneic hematopoietic stem cell transplantation (HCT) after non-myeloablative conditioning in relapsed, refractory, or transformed indolent non-hodgkin lymphoma (NHL).
    Rezvani, Andrew R.
    Sandmaier, Brenda M.
    Storer, Barry
    Maris, Michael
    Agura, Edward
    Maziarz, Richard
    Wade, James C.
    Chauncey, Thomas
    Forman, Stephen J.
    Niederwieser, Dietger W.
    Shizuru, Judith
    Langston, Amelia
    Pulsipher, Michael
    Storb, Rainer F.
    Maloney, David G.
    BLOOD, 2006, 108 (11) : 891A - 891A
  • [32] Comparison of outcomes after transplantation of peripheral blood stem cells (PBSCT) versus bone marrow (BMT) following an identical non-myeloablative conditioning regimen.
    Dey, BR
    McAfee, SL
    Colby, C
    Sackstein, R
    Saidman, S
    Tarbell, N
    Sachs, DH
    Sykes, M
    Spitzer, TR
    BLOOD, 2002, 100 (11) : 424A - 424A
  • [33] Rapid immune reconstitution and complete donor chimerism after non-myeloablative allogeneic peripheral blood stem cell transplantation (NMSCT) in pediatric patients (PTS) with malignancy
    Fry, TJ
    Rager, A
    Hakim, F
    Love, C
    Layton, P
    Fowler, D
    Bishop, MR
    Gress, R
    Mackall, CL
    Wayne, AS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 80 - 81
  • [34] Successful second allogeneic marrow transplantation following non-myeloablative conditioning for patients with relapsed/refractory lymphoma after failure of autologous transplant.
    Dey, BR
    McAfee, S
    Sackstein, R
    Colby, C
    Saidman, S
    Weymouth, D
    Poliquin, C
    Vanderklish, J
    Sachs, DH
    Sykes, M
    Spitzer, TR
    BLOOD, 2000, 96 (11) : 412A - 412A
  • [35] Non-myeloablative conditioning regimen with total lymphoid irradiation and anti-thymocyte globulin followed by infusion of allogeneic peripheral blood stem cells in patients with haematological diseases:: single-centre experience
    Messina, G.
    Spiniello, E.
    Quartarone, E.
    Fedele, R.
    Moscato, T.
    Irrera, G.
    Massara, E.
    Martino, M.
    Cuzzola, M.
    Rigolino, C.
    Meliado, A.
    Dattola, A.
    Console, G.
    Pucci, G.
    Al Sayyad, S.
    Iacopino, P.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S414 - S414
  • [36] Instability of T-cell (CD3+) mixed chimerism after day +100 in non-myeloablative allogeneic stem cell transplants.
    Theil, KS
    Warshawsky, I
    Shadrach, B
    Serafino, S
    Johnston, G
    Kalaycio, M
    Andresen, S
    Pohlman, B
    Sobecks, R
    Bolwell, BJ
    BLOOD, 2002, 100 (11) : 432B - 433B
  • [37] Large granular lymphocyte (CD3+) leukemia developing after non-myeloablative allogeneic peripheral blood stem cell transplantation.
    Bair, AK
    Coyle, TE
    Gentile, TC
    BLOOD, 2002, 100 (11) : 453B - 453B
  • [38] Cell dose and graft versus host disease (GVHD) affect survival in allogeneic peripheral blood stem cell transplantation (AlloPBSCT) following non-myeloablative (NM) conditioning: A single center experience
    Johnson, JL
    Vusirikala, M
    Chinratanalab, W
    Brandt, S
    Shyr, Y
    Shakhtour, B
    Kassim, A
    Jagasia, M
    Morgan, D
    Ruffner, K
    Stein, R
    Greer, J
    Schuening, F
    Goodman, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 45 - 45
  • [39] Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation
    Kreiter, S
    Winkelmann, N
    Schneider, PM
    Schuler, M
    Fischer, T
    Ullmann, AJ
    Huber, C
    Derigs, HG
    Kolbe, K
    BONE MARROW TRANSPLANTATION, 2001, 28 (02) : 157 - 161
  • [40] Impact of CD34+ cell dose on the outcome of patients undergoing non-myeloablative allogeneic peripheral blood stem cell transplantation (PBSCT).
    Diez-Campelo, M
    Perez-Simon, JA
    Martino, R
    Canals, C
    Caballero, D
    Mateos, V
    Sierra, J
    San Miguel, JF
    BLOOD, 2002, 100 (11) : 837A - 837A
12345